The 340B Drug Discount program continues to attract the attention of policy makers. That’s because many believe that the program has grown very fast and without appropriate oversight. This has sparked a variety of efforts…

Also in Policy Brief:

• Efforts to Address the Opioid Crisis Continue at Full Speed
  • The Battle Plan: White House Opioid Summit Recap
  • Congress and States Join the War on Opioids
• A Look at the Federal Register